Daniel N. Swisher Jr.
Chief Executive Officer, Viracta Therapeutics, Inc.
Companies
- Corcept TherapeuticsBoard member Jun 22, 2015 to now1
- CERUS CORPBoard member Jun 28, 2011 to now2
- Protagonist Therapeutics, IncBoard member Oct 30, 2023 to Oct 30, 20233
- Jazz PharmaceuticalsChief operating officer Jan 9, 2018 to Mar 7, 20234
- Jazz PharmaceuticalsPresident Jan 9, 2018 to Mar 7, 20234
- Viracta Therapeutics, Inc.Board member Oct 17, 2006 to Jul 12, 20175
- Viracta Therapeutics, Inc.Chief executive officer Oct 17, 2006 to Jul 12, 20175
- Viracta Therapeutics, Inc.President Oct 17, 2006 to Jul 12, 20175
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jazz Pharmaceuticals JAZZ55,014 shares6$11.4M at $207.05Mar 5, 2023
- CERUS CORP CERS207,045 shares7$456.5K at $2.21Jun 3, 2025
Corcept Therapeutics CORT0 shares8Oct 10, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 10, 2025Sold 2,200 shares at $87.54 of Corcept Therapeutics8
- Oct 10, 2025Exercised options 2,200 shares at $14.08 of Corcept Therapeutics8
- Sep 10, 2025Sold 2,200 shares at $72.45 of Corcept Therapeutics9
- Sep 10, 2025Exercised options 2,200 shares at $14.08 of Corcept Therapeutics9
- Aug 11, 2025Sold 2,200 shares at $72.30 of Corcept Therapeutics10
- Aug 11, 2025Exercised options 2,200 shares at $14.08 of Corcept Therapeutics10
- Jul 10, 2025Sold 2,200 shares at $71.08 of Corcept Therapeutics11
- Jul 10, 2025Exercised options 2,200 shares at $14.08 of Corcept Therapeutics11
- Jun 10, 2025Sold 2,200 shares at $70.61 of Corcept Therapeutics12
- Jun 10, 2025Exercised options 2,200 shares at $14.08 of Corcept Therapeutics12
- Jun 3, 2025Granted 60,000 shares of CERUS CORP7
- May 12, 2025Sold 400 shares at $71.55 of Corcept Therapeutics13
- May 12, 2025Sold 1,800 shares at $72.17 of Corcept Therapeutics13
- May 12, 2025Exercised options 400 shares at $14.08 of Corcept Therapeutics13
- May 12, 2025Exercised options 1,800 shares at $12.13 of Corcept Therapeutics13
- Apr 10, 2025Sold 2,200 shares at $70.22 of Corcept Therapeutics14
- Apr 10, 2025Exercised options 2,200 shares at $12.13 of Corcept Therapeutics14
- Mar 10, 2025Sold 2,200 shares at $53.60 of Corcept Therapeutics15
- Mar 10, 2025Exercised options 2,200 shares at $12.13 of Corcept Therapeutics15
- Feb 10, 2025Sold 2,200 shares at $68.08 of Corcept Therapeutics16
- Feb 10, 2025Exercised options 2,200 shares at $12.13 of Corcept Therapeutics16
- Jan 10, 2025Sold 2,200 shares at $50.54 of Corcept Therapeutics17
- Jan 10, 2025Exercised options 2,200 shares at $12.13 of Corcept Therapeutics17
- Dec 10, 2024Sold 2,200 shares at $59.46 of Corcept Therapeutics18
- Dec 10, 2024Exercised options 2,200 shares at $12.13 of Corcept Therapeutics18
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCorcept Therapeutics, Board member
- 2SEC EDGARCERUS CORP, Board member
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Sep 11, 2025
- 10SEC EDGARForm 4 filed Aug 12, 2025
- 11SEC EDGARForm 4 filed Jul 14, 2025
- 12SEC EDGARForm 4 filed Jun 12, 2025
- 13SEC EDGARForm 4 filed May 14, 2025
- 14SEC EDGARForm 4 filed Apr 14, 2025
- 15SEC EDGARForm 4 filed Mar 12, 2025
- 16SEC EDGARForm 4 filed Feb 12, 2025
- 17SEC EDGARForm 4 filed Jan 14, 2025
- 18SEC EDGARForm 4 filed Dec 12, 2024